Volume 11 Issue 3
Jun.  2021
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Analysis  > 2021  >  11(3): 257-264
Congshan Jiang, Xiaowei Li, Changrong Ge, Yuanyuan Ding, Tao Zhang, Shuai Cao, Liesu Meng, Shemin Lu. Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection[J]. Journal of Pharmaceutical Analysis, 2021, 11(3): 257-264. doi: 10.1016/j.jpha.2021.03.006
Citation: Congshan Jiang, Xiaowei Li, Changrong Ge, Yuanyuan Ding, Tao Zhang, Shuai Cao, Liesu Meng, Shemin Lu. Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection[J]. Journal of Pharmaceutical Analysis, 2021, 11(3): 257-264. doi: 10.1016/j.jpha.2021.03.006
shu

Molecular detection of SARS-CoV-2 being challenged by virus variation and asymptomatic infection

doi: 10.1016/j.jpha.2021.03.006

  • a. Institute of Molecular and Translational Medicine (IMTM); Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Xi’an Jiaotong University Health Science Center, 76 West Yanta Road, Xi’an, Shaanxi, 710061, PR China;

  • b. Key Laboratory of Environment and Genes Related to Diseases (Xi’an Jiaotong University), Ministry of Education, Xi’an, Shaanxi, 710061, PR China;

  • c. Section for Medical Inflammation Research, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 17177, Sweden;

  • d. School of Pharmacy, Xi’an Jiaotong University Health Science Center, 76 West Yanta Road, Xi’an, Shaanxi, 710061, PR China;

  • e. Department of Orthopedics, The Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, 710004, PR China

Funds:

This work was supported by the National Natural Science Foundation of China (project No. 81970029), Fundamental Research Funds for the Central Universities of China (The Emergency Projects on COVID-19, xzy032020042), and Qinnong Bank-XJTU special project for COVID-19 (qnxjtu-12).

  • Received Date: Feb. 25, 2021
  • Accepted Date: Mar. 22, 2021
  • Rev Recd Date: Mar. 17, 2021
  • Available Online: Jan. 24, 2022
  • Publish Date: Jun. 15, 2021
    Abstract
  • Coronavirus disease 2019 (COVID-19) has been a pandemic for more than a year. With the expanding second wave of the pandemic in winter, the continuous evolution of SARS-CoV-2 has brought new issues, including the significance of virus mutations in infection and the detection of asymptomatic infection. In this review, we first introduced several major SARS-CoV-2 mutations since the COVID-19 outbreak and then mentioned the widely used molecular detection techniques to diagnose COVID-19, primarily focusing on their strengths and limitations. We further discussed the effects of viral genetic variation and asymptomatic infection on the molecular detection of SARS-CoV-2 infection. The review finally summarized useful insights into the molecular diagnosis of COVID-19 under the special situation being challenged by virus mutation and asymptomatic infection.
    • FullText(HTML)
  • loading
    • References(81)
  • P. Zhou, X. L. Yang, X. G. Wang, et al., A pneumonia outbreak associated with a new coronavirus of probable bat origin, Nature 579 (2020) 270-273
    X. W. Li, M. M. Geng, Y. Z. Peng, et al., Molecular immune pathogenesis and diagnosis of COVID-19, J Pharm Anal 10 (2020) 102-108
    J. A. Sheikh, J. Singh, H. Singh, et al., Emerging genetic diversity among clinical isolates of SARS-CoV-2: Lessons for today, Infect Genet Evol 84 (2020) 104330
    B. Korber, W. M. Fischer, S. Gnanakaran, et al., Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus, Cell 182 (2020) 812-827
    F. Wu, S. Zhao, B. Yu, et al., A new coronavirus associated with human respiratory disease in China, Nature 579 (2020) 265-269
    S. Wang, Z. Qiu, Y. Hou, et al., AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells, Cell research 31 (2021) 126-140
    C. Wei, L. Wan, Q. Yan, et al., HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry, Nature metabolism 2 (2020) 1391-1400
    D. Wrapp, N. S. Wang, K. S. Corbett, et al., Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 367 (2020) 1260-1263
    Y. Peng, N. Du, Y. Q. Lei, et al., Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design, Embo J 39 (2020) e105938
    L. Ni, F. Ye, M. L. Cheng, et al., Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals, Immunity 52 (2020) 971-977
    V. S. Mandala, M. J. McKay, A. A. Shcherbakov, et al., Structure and drug binding of the SARS-CoV-2 envelope protein transmembrane domain in lipid bilayers, Nat Struct Mol Biol 27 (2020) 1202-1208
    Y. Zheng, M. W. Zhuang, L. L. Han, et al., Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling, Signal Transduct Tar 5 (2020) 299
    S. Su, G. Wong, W. F. Shi, et al., Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses, Trends Microbiol 24 (2016) 490-502
    F. Ferron, L. Subissi, A. T. S. De Morais, et al., Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA, P Natl Acad Sci USA 115 (2018) E162-E171
    J. H. Chen, R. Wang, M. L. Wang, et al., Mutations Strengthened SARS-CoV-2 Infectivity, J Mol Biol 432 (2020) 5212-5226
    H. Tegally, E. Wilkinson, M. Giovanetti, et al., Emergence of a SARS-CoV-2 variant of concern with mutations in spike glycoprotein Nature (2021). https://doi.org/10.1038/s41586-021-03402-9
    N. G. Davies, R. C. Barnard, C. I. Jarvis, et al., Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England, MedRxiv (2020) 2020.2012.2021.20248640. https://doi.org/10.1101/2020.12.24.20248822
    J. A. Plante, Y. Liu, J. Y. Liu, et al., Spike mutation D614G alters SARS-CoV-2 fitness, Nature (2020). https://doi.org/10.1038/s41586-020-2895-3
    D. Weissman, M. G. Alameh, T. de Silva, et al., D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization, Cell Host Microbe 29 (2021) 23-31
    N. D. Grubaugh, W. P. Hanage and A. L. Rasmussen, Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear, Cell 182 (2020) 794-795
    T. N. Starr, A. J. Greaney, S. K. Hilton, et al., Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding, Cell 182 (2020) 1295-1310
    M. Hoffmann, H. Kleine-Weber and S. Pohlmann, A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells, Mol Cell 78 (2020) 779-784
    S. Kemp, W. Harvey, R. Datir, et al., Recurrent emergence and transmission of a SARS-CoV-2 Spike deletion ΔH69/V70, SSRN Electronic Journal (2021). https://doi.org/10.2139/ssrn.3780277
    J. Lan, J. W. Ge, J. F. Yu, et al., Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature 581 (2020) 215-220
    C. Y. Yi, X. Y. Sun, J. Ye, et al., Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies, Cell Mol Immunol 17 (2020) 621-630
    L. J. Carter, L. V. Garner, J. W. Smoot, et al., Assay Techniques and Test Development for COVID-19 Diagnosis, Acs Central Sci 6 (2020) 591-605
    V. M. Corman, O. Landt, M. Kaiser, et al., Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR, Eurosurveillance 25 (2020) 23-30
    C. Sheridan, Coronavirus and the race to distribute reliable diagnostics, Nat Biotechnol 38 (2020) 382-384
    X. Z. Xie, Z. Zhong, W. Zhao, et al., Chest CT for Typical Coronavirus Disease 2019 (COVID-19) Pneumonia: Relationship to Negative RT-PCR Testing, Radiology 296 (2020) E41-E45
    F. Wu and W. S. Huang, COVID-19 diagnostic process in mainland China: The math beyond pneumonia, J Allergy Clin Immun 146 (2020) 64-66
    A. N. Tavare, A. Braddy, S. Brill, et al., Managing high clinical suspicion COVID-19 inpatients with negative RT-PCR: a pragmatic and limited role for thoracic CT, Thorax 75 (2020) 537-538
    F. Mei, M. Bonifazi, S. Menzo, et al., First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid, Chest 158 (2020) E143-E146
    T. J. Harkin, K. M. Rurak, J. Martins, et al., Delayed diagnosis of COVID-19 in a 34-year-old man with atypical presentation, Lancet Resp Med 8 (2020) 644-646
    R. Gross, C. Conzelmann, J. A. Muller, et al., Detection of SARS-CoV-2 in human breastmilk, Lancet 395 (2020) 1757-1758
    C. B. F. Vogels, A. F. Brito, A. L. Wyllie, et al., Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets, Nat Microbiol 5 (2020) 1299-1305
    V. Stadnytskyi, C. E. Bax, A. Bax, et al., The airborne lifetime of small speech droplets and their potential importance in SARS-CoV-2 transmission, P Natl Acad Sci USA 117 (2020) 11875-11877
    W. Chen, B. Cai, Z. Geng, et al., Reducing False Negatives in COVID-19 Testing by Using Microneedle-Based Oropharyngeal Swabs, Matter-Us 3 (2020) 1589-1600
    L. Mutesa, P. Ndishimye, Y. Butera, et al., A pooled testing strategy for identifying SARS-CoV-2 at low prevalence, Nature 589 (2021) 276-280
    A. Ganguli, A. Mostafa, J. Berger, et al., Rapid isothermal amplification and portable detection system for SARS-CoV-2, P Natl Acad Sci USA 117 (2020) 22727-22735
    V. L. D. Thi, K. Herbst, K. Boerner, et al., A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples, Sci Transl Med 12 (2020) eabc7075
    J. Qian, S. A. Boswell, C. Chidley, et al., An enhanced isothermal amplification assay for viral detection, Nat Commun 11 (2020) 5920
    S. M. Xia and X. Chen, Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA, Cell Discov 6 (2020) 37
    M. Deiana, A. Mori, C. Piubelli, et al., Assessment of the direct quantitation of SARS-CoV-2 by droplet digital PCR, Sci Rep-Uk 10 (2020) 18764
    R. A. Bull, T. N. Adikari, J. M. Ferguson, et al., Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis, Nat Commun 11 (2020) 6272
    A. Wajnberg, M. Mansour, E. Leven, et al., Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study, Lancet Microbe (2020) 283-289
    J. Lu, J. J. Peng, Q. L. Xiong, et al., Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR, Ebiomedicine 59 (2020) 102960
    R. S. Xu, B. M. Cui, X. B. Duan, et al., Saliva: potential diagnostic value and transmission of 2019-nCoV, Int J Oral Sci 12 (2020) 11
    T. Y. Hou, W. Q. Zeng, M. L. Yang, et al., Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19, Plos Pathog 16 (2020) e1008705
    J. Arizti-Sanz, C. A. Freije, A. C. Stanton, et al., Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2, Nat Commun 11 (2020) 5921
    X. Ding, K. Yin, Z. Y. Li, et al., Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay, Nat Commun 11 (2020) 4711
    B. Ning, T. Yu, S. Zhang, et al., A smartphone-read ultrasensitive and quantitative saliva test for COVID-19, Sci Adv 7 (2021) eabe3703
    L. F. Zhou, A. R. Chandrasekaran, J. A. Punnoose, et al., Programmable low-cost DNA-based platform for viral RNA detection, Sci Adv 6 (2020) eabc6246
    W. Feng, A. M. Newbigging, C. Le, et al., Molecular Diagnosis of COVID-19: Challenges and Research Needs, Anal Chem 92 (2020) 10196-10209
    W. J. Wiersinga, A. Rhodes, A. C. Cheng, et al., Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review, Jama-J Am Med Assoc 324 (2020) 782-793
    C. R. Zamecnik, J. V. Rajan, K. A. Yamauch, et al., ReScan, a Multiplex Diagnostic Pipeline, Pans Human Sera for SARS-CoV-2 Antigens, Cell Reports Medicine (2020) 100123
    Z. Zhang, Z. Tang, N. Farokhzad, et al., Sensitive, Rapid, Low-Cost, and Multiplexed COVID-19 Monitoring by the Wireless Telemedicine Platform, Matter-Us 3 (2020) 1818-1820
    H. W. Jiang, Y. Li, H. N. Zhang, et al., SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses, Nat Commun 11 (2020) 3581
    N. Vabret, G. J. Britton, C. Gruber, et al., Immunology of COVID-19: Current State of the Science, Immunity 52 (2020) 910-941
    L. Grzelak, S. Temmam, C. Planchais, et al., A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations, Sci Transl Med 12 (2020) eabc3103
    K. Roltgen, A. E. Powell, O. F. Wirz, et al., Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome, Sci Immunol 5 (2020) eabe0240
    B. Isho, K. T. Abe, M. Zuo, et al., Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients, Sci Immunol 5 (2020) eabe5511
    Z. T. Li, Y. X. Yi, X. M. Luo, et al., Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis, J Med Virol 92 (2020) 1518-1524
    M. Nuccetelli, M. Pieri, S. Grelli, et al., SARS-CoV-2 infection serology: a useful tool to overcome lockdown?, Cell Death Discov 6 (2020) 38
    M. K. Ozcurumez, A. Ambrosch, O. Frey, et al., SARS-CoV-2 antibody testing-questions to be asked, J Allergy Clin Immun 146 (2020) 35-43
    J. V. Dzimianski, N. Lorig-Roach, S. M. O’Rourke, et al., Rapid and sensitive detection of SARS-CoV-2 antibodies by biolayer interferometry, Sci Rep-Uk 10 (2020) 21738
    R. R. de Assis, A. Jain, R. Nakajima, et al., Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray, Nat Commun 12 (2021) 6
    S. Uyoga, A. I. M. O., K. H. K, et al., Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors, Science 371 (2021) 79-82
    R. W. Peeling, C. J. Wedderburn, P. J. Garcia, et al., Serology testing in the COVID-19 pandemic response, Lancet Infect Dis 20 (2020) E245-E249
    C. F. Houlihan and R. Beale, The complexities of SARS-CoV-2 serology, Lancet Infect Dis 20 (2020) 1350-1351
    Y. S. Wang, S. H. Sun, H. Shen, et al., Cross-Reaction of SARS-CoV Antigen with Autoantibodies in Autoimmune Diseases, Cell Mol Immunol 1 (2004) 304-307
    L. Goetz, J. Yang, W Greene.L. Goetz, J. Yang, W Greene., et al., A COVID-19 petient with repeatedly undetectable SARS-CoV-2 antibodies, The journal of applied laboratory medicine 5 (2020) 1401-1405
    K. J. Ewer, J. R. Barrett, S. Belij-Rammerstorfer, et al., T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial, Nat Med 27 (2021) 270-278
    K. W. Ng, N. Faulkner, G. H. Cornish, et al., Preexisting and de novo humoral immunity, Science 370 (2020) 1339-1343
    M. J. Mosko, A. A. Nakorchevsky, E. Flores, et al., Ultrasensitive detection of multiplexed somatic mutations using MALDI-TOF mass spectrometry, J. Mol. Diagn. 18 (2016) 23-31
    M. Artesi, S. Bontems, P. Gobbels, et al., A Recurrent Mutation at Position 26340 of SARS-CoV-2 Is Associated with Failure of the E Gene Quantitative Reverse Transcription-PCR Utilized in a Commercial Dual-Target Diagnostic Assay, J Clin Microbiol 58 (2020) e01598-01520
    T. Nakabayashi, Y. Kawasaki, M. K., et al., Evaluation of the effects of SARS-CoV-2 genetic mutations on diagnostic RT-PCR assays, bioRxiv (2021) 2021.2001.2019.426622. https://doi.org/10.1101/2021.01.19.426622
    C. O. Barnes, A. P. West, K. E. Huey-Tubman, et al., Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies, Cell 182 (2020) 828-842
    N. Shental, S. Levy, V. Wuvshet, et al., Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers, Sci Adv 6 (2020) eabc5961
    D. B. Larremore, B. Wilder, E. Lester, et al., Test sensitivity is secondary to frequence and turnaround time for COVID-19 screening, Sci Adv 7 (2021) eabd5393
    D. K. W. Chu, Y. Pan, S. M. S. Cheng, et al., Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia, Clin Chem 66 (2020) 549-555
    M. Patchsung, K. Jantarug, A. Pattama, et al., Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA, Nat Biomed Eng 4 (2020) 1140-1149
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (159) PDF downloads(2) Cited by()
    Proportional views
    Related

    Copyright © Journal of Pharmaceutical Analysis

    E-mail: jpa2011@126.com;  jpasubmit@126.com;  jpaeditor@xjtu.edu.cn   Tel:+86-029-88960092

    Address: Western China Science and Technology Innovation Harbour, Xixian New Area, Xi’an, 712000, China

    Email alert RSS

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return